XML 47 R40.htm IDEA: XBRL DOCUMENT v3.21.4
CONTRACTUAL OBLIGATIONS (Narrative) (Details)
 1 Months Ended 4 Months Ended 5 Months Ended 10 Months Ended 12 Months Ended
Nov. 06, 2020
USD ($)
Oct. 09, 2020
USD ($)
Shares
Jun. 05, 2020
Shares
Aug. 31, 2021
USD ($)
Apr. 23, 2021
CAD ($)
shares
Apr. 23, 2021
USD ($)
shares
Mar. 31, 2021
USD ($)
Jan. 31, 2021
Shares
Nov. 17, 2020
USD ($)
Shares
May 26, 2020
CAD ($)
May 26, 2020
USD ($)
Sep. 30, 2019
CAD ($)
Apr. 28, 2021
Shares
Apr. 12, 2021
USD ($)
Sep. 30, 2021
CAD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
CAD ($)
Disclosure Of Contractual Obligation [Line Items]                                  
Research and development expense                       $ 42,009     $ 6,313,988   $ 354,852
Option agreement [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Non-refundable option fees paid                   $ 20,313 $ 15,000            
License agreement [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Signing fee           $ 100,000                      
Option fees paid           $ 15,000                      
Signing fee, net of option fees paid         $ 105,502                        
Signing fee, shares issued | shares         63,000 63,000                      
Percentage of royalties on net sales under $1 billion         3.00% 3.00%                      
Percentage of royalties on net sales over $2 billion         4.50% 4.50%                      
Description of sublicensee revenue of royalty payment accrues         royalty payments being credited toward the annual minimum for the license year in which the royalty payment accrues and 12% on all non-royalty revenue until the Company has raised $7.5 million and then 10% thereafter royalty payments being credited toward the annual minimum for the license year in which the royalty payment accrues and 12% on all non-royalty revenue until the Company has raised $7.5 million and then 10% thereafter                      
Annual minimum royalties - Years 1 and 2                                
Annual minimum royalties - Year 3         5,000                        
Annual minimum royalties - Year 4         15,000                        
Annual minimum royalties - Year 5         35,000                        
Annual minimum royalties - Year 6 and thereafter         50,000                        
Annual minimum royalties after first commercial sale         250,000                        
Licensing agreement - prior to any sublicensing agreements, joint ventures or change of control [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Milestone payments upon dosing first patient in Phase I trial         10,000                        
Milestone payments upon dosing first patient in the first Phase II trial         50,000                        
Milestone payments upon dosing first patient in the first Phase III trial         250,000                        
Milestone payments upon first commercial sale of each clinical indication         2,000,000                        
Licensing agreement - after any sublicensing agreements, joint ventures or change of control [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Milestone payments upon dosing first patient in the first Phase II trial         250,000                        
Milestone payments upon dosing first patient in the first Phase III trial         500,000                        
Milestone payments upon first commercial sale of each clinical indication         $ 2,000,000                        
Independent Consultant Agreement [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Number of options granted | Shares     150,000                            
Number of RSUs granted | Shares     150,000                            
Monthly fee authorized by board of directors       $ 25,000     $ 15,000                    
Independent Contractor Agreement [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Monthly fee authorized by board of directors       $ 25,000     $ 15,000                    
Scientific advisory board agreements [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Number of options granted | Shares                 130,000                
Number of options cancelled | Shares               20,000                  
Scientific advisory board agreements [Member] | Bottom of range [member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Advisor hourly rate                           $ 150      
Scientific advisory board agreements [Member] | Top of range [member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Advisor hourly rate                           $ 160      
Consulting agreements [Member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Number of options granted | Shares   90,000                     302,000        
Monthly fee authorized by board of directors                 $ 15,000                
Advisor hourly rate   $ 130                              
Research and development expense $ 66,764                                
Consulting agreements [Member] | Bottom of range [member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Advisor hourly rate                               $ 30  
Consulting agreements [Member] | Top of range [member]                                  
Disclosure Of Contractual Obligation [Line Items]                                  
Advisor hourly rate                               $ 600